Research and experimental development on natural sciences and engineering
ONCOSYNE AS
Revenue 2024
NOK 4.4m
Operating profit
NOK −2.0m
Equity
NOK 10.8m
Incorporated
2020
Employees
6
Share capital
NOK 1.1m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 4.4m | |
| Total operating costs | 6.4m | |
| Operating profit (EBIT) | −2.0m | |
| Net financial items | 260k | |
| Profit for the year | −1.7m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 12.0m | |
| of which current assets | 11.1m | |
| Equity | 10.8m | |
| Total liabilities | 1.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.